105 related articles for article (PubMed ID: 33430748)
1. In Silico Prediction and Designing of Potential siRNAs to be used as Antivirals Against SARS-CoV-2.
Sohrab SS; El-Kafrawy SA; Abbas AT; Bajrai LH; Azhar EI
Curr Pharm Des; 2021; 27(32):3490-3500. PubMed ID: 33430748
[TBL] [Abstract][Full Text] [Related]
2. In silico prediction and experimental evaluation of potential siRNAs against SARS-CoV-2 inhibition in Vero E6 cells.
Sartaj Sohrab S; Aly El-Kafrawy S; Ibraheem Azhar E
J King Saud Univ Sci; 2022 Jun; 34(4):102049. PubMed ID: 35493709
[TBL] [Abstract][Full Text] [Related]
3. Genomic characterization and phylogenetic evolution of the SARS-CoV-2.
Zhang RH; Ai X; Liu Y; Li CH; Zhang HL
Acta Virol; 2020; 64(4):496-500. PubMed ID: 32985209
[TBL] [Abstract][Full Text] [Related]
4. Effect of insilico predicted and designed potential siRNAs on inhibition of SARS-CoV-2 in HEK-293 cells.
Sohrab SS; El-Kafrawy SA; Azhar EI
J King Saud Univ Sci; 2022 Jun; 34(4):101965. PubMed ID: 35313445
[TBL] [Abstract][Full Text] [Related]
5. Current understanding of an Emerging Coronavirus using in silico approach: Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2).
Khalid S; Siddique R; Shaheen S; Shahid MN; Shamim Z; Khan MKA; Serçe ÇU
Braz J Biol; 2021; 83():e247237. PubMed ID: 34495154
[TBL] [Abstract][Full Text] [Related]
6. Evitar: designing anti-viral RNA therapies against future RNA viruses.
Zhang D; Tian J; Wang Y; Lu J
Bioinformatics; 2022 Apr; 38(9):2437-2443. PubMed ID: 35294970
[TBL] [Abstract][Full Text] [Related]
7. The Emergence of Human Pathogenic Coronaviruses: Lectins as Antivirals for SARS-CoV-2.
Sohrab SS; Suhail M; Kamal MA; Ahmad F; Azhar EI
Curr Pharm Des; 2020; 26(41):5286-5292. PubMed ID: 32954998
[TBL] [Abstract][Full Text] [Related]
8. Recognition of plausible therapeutic agents to combat COVID-19: An omics data based combined approach.
Hossain MU; Bhattacharjee A; Emon MTH; Chowdhury ZM; Mosaib MG; Mourin M; Das KC; Keya CA; Salimullah M
Gene; 2021 Mar; 771():145368. PubMed ID: 33346100
[TBL] [Abstract][Full Text] [Related]
9. Prediction of putative potential siRNAs for inhibiting SARS-CoV-2 strains, including variants of concern and interest.
Saba AA; Adiba M; Chakraborty S; Nabi AN
Future Microbiol; 2022 Apr; 17():449-463. PubMed ID: 35285248
[No Abstract] [Full Text] [Related]
10. Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CL
Chitranshi N; Gupta VK; Rajput R; Godinez A; Pushpitha K; Shen T; Mirzaei M; You Y; Basavarajappa D; Gupta V; Graham SL
J Transl Med; 2020 Jul; 18(1):278. PubMed ID: 32646487
[TBL] [Abstract][Full Text] [Related]
11. In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.
Signer J; Jonsdottir HR; Albrich WC; Strasser M; Züst R; Ryter S; Ackermann-Gäumann R; Lenz N; Siegrist D; Suter A; Schoop R; Engler OB
Virol J; 2020 Sep; 17(1):136. PubMed ID: 32907596
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study.
Ren LL; Wang YM; Wu ZQ; Xiang ZC; Guo L; Xu T; Jiang YZ; Xiong Y; Li YJ; Li XW; Li H; Fan GH; Gu XY; Xiao Y; Gao H; Xu JY; Yang F; Wang XM; Wu C; Chen L; Liu YW; Liu B; Yang J; Wang XR; Dong J; Li L; Huang CL; Zhao JP; Hu Y; Cheng ZS; Liu LL; Qian ZH; Qin C; Jin Q; Cao B; Wang JW
Chin Med J (Engl); 2020 May; 133(9):1015-1024. PubMed ID: 32004165
[TBL] [Abstract][Full Text] [Related]
13. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
Froggatt HM; Heaton BE; Heaton NS
J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
[TBL] [Abstract][Full Text] [Related]
14. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
[TBL] [Abstract][Full Text] [Related]
15. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].
Lvov DK; Alkhovsky SV
Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561
[TBL] [Abstract][Full Text] [Related]
16. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
Kumar Y; Singh H; Patel CN
J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
[TBL] [Abstract][Full Text] [Related]
17. [Etiology of epidemic outbreaks COVID-19 on Wuhan, Hubei province, Chinese People Republic associated with 2019-nCoV (Nidovirales, Coronaviridae, Coronavirinae, Betacoronavirus, Subgenus Sarbecovirus): lessons of SARS-CoV outbreak.].
Lvov DK; Alkhovsky SV; Kolobukhina LV; Burtseva EI
Vopr Virusol; 2020; 65(1):6-15. PubMed ID: 32496715
[TBL] [Abstract][Full Text] [Related]
18. In Vitro Inhibitory Analysis of Rationally Designed siRNAs against MERS-CoV Replication in Huh7 Cells.
El-Kafrawy SA; Sohrab SS; Mirza Z; Hassan AM; Alsaqaf F; Azhar EI
Molecules; 2021 Apr; 26(9):. PubMed ID: 33947034
[TBL] [Abstract][Full Text] [Related]
19. Full-genome sequences of the first two SARS-CoV-2 viruses from India.
Yadav PD; Potdar VA; Choudhary ML; Nyayanit DA; Agrawal M; Jadhav SM; Majumdar TD; Shete-Aich A; Basu A; Abraham P; Cherian SS
Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):200-209. PubMed ID: 32242873
[TBL] [Abstract][Full Text] [Related]
20. Computational study and design of effective siRNAs to silence structural proteins associated genes of Indian SARS-CoV-2 strains.
Madanagopal P; Muthukumar H; Thiruvengadam K
Comput Biol Chem; 2022 Jun; 98():107687. PubMed ID: 35537364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
